CaRe Clinic Joins hyperCORE International to Expand Global Clinical Research Capabilities

The clinical research landscape is undergoing significant transformation as CaRe Clinic, a prominent multi-specialty research organization based in Alberta, Canada, joins hyperCORE International's collaborative super network. This strategic alliance represents a substantial expansion of hyperCORE's global reach and capabilities in conducting clinical trials across multiple therapeutic areas. The partnership brings together complementary strengths that could revolutionize how clinical research is conducted internationally.

CaRe Clinic contributes two state-of-the-art, dedicated research centers serving Calgary and Red Deer, along with the central regions of Alberta. The organization has demonstrated expertise through participation in hundreds of clinical trials across diverse medical fields including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. This multi-therapeutic expertise positions the partnership to address complex medical challenges across various patient populations and conditions.

One of the most significant assets CaRe Clinic brings to the partnership is its extensive patient database. Through investigators' databases and strong partnerships with affiliated clinics, the organization maintains access to a potential patient pool exceeding 1.8 million individuals. This vast resource, combined with CaRe Clinic's community-centric recruitment strategy, provides unprecedented participant recruitment capabilities across numerous medical indications. The integration of this patient network with hyperCORE's global infrastructure creates one of the most comprehensive clinical trial recruitment systems in the industry.

Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the partnership's broader implications, noting that it enables unprecedented collaboration and sharing of best practices across borders, which is crucial for clinical research advancement. The collaboration aims to highlight Canada's robust clinical research ecosystem globally while contributing to pioneering breakthroughs benefiting patients worldwide. This international cooperation reflects a growing trend toward more integrated clinical research networks that transcend geographical boundaries.

hyperCORE International, already an industry leader in providing Phase I-IV clinical trial services, significantly expands its Canadian presence through this partnership. The organization's global footprint now spans two continents and five countries, with more than 120 active research sites. Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the immediate expansion of hyperCORE's footprint at multiple Canadian locations with multi-therapeutic offerings.

The collaboration leverages hyperCORE International's decades of clinical research experience, with alliance partners having completed more than 7,000 studies and evaluated thousands of new drugs and treatments in over 150,000 randomized patients. The organization maintains commitment to research excellence through prioritizing subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention. These established protocols combined with CaRe Clinic's recruitment capabilities create a powerful synergy for addressing clinical trial challenges.

This partnership is expected to accelerate clinical research and drug development timelines, potentially leading to faster medical breakthroughs across therapeutic areas. By addressing critical challenges in patient recruitment and retention through combined resources, the alliance represents a new model for efficient clinical trial execution. For the broader medical and pharmaceutical industries, this collaboration signifies the growing importance of integrated, globally connected research networks in advancing medical science and bringing new treatments to patients more rapidly and effectively.